US Patent

US9447089 — Compositions and uses thereof

Formulation · Assigned to Hoffmann La Roche Inc · Expires 2032-06-06 · 6y remaining

Vulnerability score 42/100 Strong — defensible against typical IPR challenges

What this patent protects

This patent protects compositions and uses of solid dispersions, complexes, salts, and crystalline polymorphs of a specific compound.

USPTO Abstract

Provided are solid dispersions, solid molecular complexes, salts and crystalline polymorphs involving propane-1-sulfonic acid {3-[5-(4-chloro-phenyl)-1H-pyrrolo[2,3-b]pyridine-3-carbonyl]-2,4-difluoro-phenyl}-amide.

Drugs covered by this patent

Patent Metadata

Patent number
US9447089
Jurisdiction
US
Classification
Formulation
Expires
2032-06-06
Drug substance claim
No
Drug product claim
Yes
Assignee
Hoffmann La Roche Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.